Article

Cannula approach using posterior delivery brings unparalleled safety

Posterior juxtascleral injection of he angiostatic steroid analog anecortave acetate (Alcon) has been associated with a remarkable safety profile in clinical trials evaluating it for the treatment of subfoveal choroidal neorvascularization (CNV) associated with age-related macular degeneration (AMD).

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.